Why this ASX medical technology share surged 43% higher today

The Medadvisor Ltd (ASX: MDR) share price is surging higher today after the company provided an update on the role it is playing in the coronavirus outbreak.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Medadvisor Ltd (ASX: MDR) share price is surging higher today after the company provided an update on the role it is playing in the coronavirus outbreak.

After rocketing as much as 42.86% higher to $0.45 in early afternoon trade, MedAdvisor shares are now sitting at $0.39 at the time of writing, up 23.81%.

MedAdvisor is an Australian software systems developer. The company has a free app that connects to pharmacy dispensing systems to automatically retrieve medication records and also links to a training, information and reminder system to ensure correct medication use.

What did MedAdvisor announce today?

Today, MedAdvisor announced that it will enable Australian pharmacies to receive and process requests for medication delivery through its MedAdvisor App. The company will also offer pharmacies a temporary discount to the cost of its messaging service to all of their patients and enable patients to order from home.

Additionally, MedAdvisor will provide any pharmacies that are not a current customer an initial two month free trial of its platform. Currently, 60% of all pharmacies throughout Australia use its service.

How MedAdvisor can help the current healthcare crisis

MedAdvisor noted that it is set to play a crucial role in facilitating pharmacy home delivery following recent Federal Government funding. Last week, the Government announced it will provide $25 million to support pharmacies to home deliver medications, ensuring that isolated people can get the pharmaceutical items that they require by filling in their prescriptions remotely.

MedAdvisor further noted that patients have the option to remotely order prescriptions from a GP via its app. By pre-ordering in advance, this improves pharmacy workflow by helping pharmacies to more efficiently manage stock and also takes some burden off a stretched GP system.

In addition, Australian pharmacies can send or receive messages to patients through the MedAdvisor App and its partner apps provided by a range of Australian pharmacy chains including Amcal and Terry White.

Strong increase in ordering platform over the past week

MedAdvisor noted a significant increase in orders per pharmacy over the past week, particularly in the last 2 days.

To date, 57% of orders through the company's platform occur outside of normal business hours and MedAdvisor is expecting the volume of orders to increase significantly.

Recap of recent financial results

At the end of February, MedAdvisor reported its half year FY 2020 results, revealing operating revenue of $4.4 million, up by 14.4% on the prior corresponding period of 1H19.

Gross profit increased 14.4% to $3.9 million during the period, while gross margins remained stable at 87.6%. MedAdvisor commented that the international markets in which it operates represent a significant opportunity for growth.

Motley Fool contributor Phil Harpur has no position in any of the stocks mentioned. The Motley Fool Australia has recommended MedAdvisor. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why EML, GQG Partners, IGO, and Integrated Research shares are sinking today

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a strong gain. At the time of…

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why EOS, News Corp, Polynovo, and Pro Medicus shares are roaring higher today

These shares are starting the week positively. But why?

Read more »

A couple stares at the tv in shock, one holding the remote up ready to press.
Mergers & Acquisitions

Telstra share price climbs amid $3.4b Foxtel sale

Who is buying the Foxtel business? Let's find out.

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Share Market News

Brokers say these ASX 200 growth stocks could rise 50% to 70%

Analysts think these shares could be dirt cheap and destined to generate big returns.

Read more »

Two people having a meeting using a laptop and tablet to discuss Seven West Media's balance sheet
Broker Notes

Why these ASX shares could be top SMSF options in 2025

Analysts are bullish on these high-quality shares. Let's find out why.

Read more »

The words short selling in red against a black background
Share Market News

These are the 10 most shorted ASX shares

Let's see which shares short sellers are targeting this week.

Read more »

Smiling man with phone in wheelchair watching stocks and trends on computer
Share Market News

5 things to watch on the ASX 200 on Monday

A good start to the week is expected for Aussie investors. Here's what to watch.

Read more »

A businessman compares the growth trajectory of property versus shares.
Opinions

What's the outlook for shares vs. property in 2025?

The experts have put out their new year predictions...

Read more »